Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins

Infection and Immunity

Volumn 76, Issue 8, 2008, Pages 3405-3414

  Huang, Haibin ^a,c   Lin, Mingqun ^a   Wang, Xueqi ^a   Kikuchi, Takane ^a   Mottaz, Heather ^b   Norbeck, Angela ^b   Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; GLOBOMYCIN; LIPOPROTEIN; SIGNAL PEPTIDASE II; BACTERIAL PROTEIN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CELL CULTURE; CELL STRAIN HL 60; CONTROLLED STUDY; DOG; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEOMICS; RICKETTSIALES; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; BLOOD; CELL LINE; DELAYED HYPERSENSITIVITY; DOG DISEASE; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CHROMATOGRAPHY, LIQUID; DOG DISEASES; DOGS; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; LIPOPROTEINS; MALE; MOLECULAR SEQUENCE DATA; PROTEOMICS; SEQUENCE ALIGNMENT; TANDEM MASS SPECTROMETRY;

EID: 48849086594     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00056-08     Document Type: Article

References (55)

1. Adkins, J. N., H. M. Mottaz, A. D. Norbeck, J. K. Gustin, J. Rue, T. R. Clauss, S. O. Purvine, K. D. Rodland, F. Heffron, and R. D. Smith. 2006. Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions. Mol. Cell. Proteomics 5:1450-1461.
2. Anderson, B. E., J. E. Dawson, D. C. Jones, and K. H. Wilson. 1991. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 29:2838-2842.
3. Anderson, B. E., J. W. Sumner, J. E. Dawson, T. Tzianabos, C. R. Greene, J. G. Olson, D. B. Fishbein, M. Olsen-Rasmussen, B. P. Holloway, E. H. George, et al. 1992. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J. Clin. Microbiol. 30:775-780.
4. Bas, S., L. Neff, M. Vuillet, U. Spenato, T. Seya, M. Matsumoto, and C. Gabay. 2008. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol. 180:1158-1168.
5. Bitsaktsis, C., J. Huntington, and G. Winslow. 2004. Production of IFN-γ by CD4 T cells is essential for resolving Ehrlichia infection. J. Immunol. 172:6894-6901.
6. Cabral, E. S., H. Gelderblom, R. L. Hornung, P. J. Munson, R. Martin, and A. R. Marques. 2006. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J. Infect. Dis. 193:849-859.
7. Dawson, J. E., B. E. Anderson, D. B. Fishbein, J. L. Sanchez, C. S. Goldsmith, K. H. Wilson, and C. W. Duntley. 1991. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J. Clin. Microbiol. 29:2741-2745.
8. Dawson, J. E., K. L. Biggie, C. K. Warner, K. Cookson, S. Jenkins, J. F. Levine, and J. G. Olson. 1996. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am. J. Vet. Res. 57:1175-1179.
9. Demma, L. J., R. C. Holman, J. H. McQuiston, J. W. Krebs, and D. L. Swerdlow. 2005. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am. J. Trop. Med. Hyg. 73:400-409.
10. Dunning Hotopp, J. C., M. Lin, R. Madupu, J. Crabtree, S. V. Angiuoli, J. Eisen, R. Seshadri, Q. Ren, M. Wu, T. R. Utterback, S. Smith, M. Lewis, H. Khouri, C. Zhang, H. Niu, Q. Lin, N. Ohashi, N. Zhi, W. Nelson, L. M. Brinkac, R. J. Dodson, M. J. Rosovitz, J. Sundaram, S. C. Daugherty, T. Davidsen, A. S. Durkin, M. Gwinn, D. H. Haft, J. D. Selengut, S. A. Sullivan, N. Zafar, L. Zhou, F. Benahmed, H. Forberger, R. Halpin, S. Mulligan, J. Robinson, O. White, Y. Rikihisa, and H. Tettelin. 2006. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet. 2:e21.
11. Ge, Y., and Y. Rikihisa. 2007. Surface-exposed proteins of Ehrlichia chaffeensis. Infect. Immun. 75:3833-3841.
12. Gupta, S. D., and H. C. Wu. 1991. Identification and subcellular localization of apolipoprotein N-acyltransferase in Escherichia coli. FEMS Microbiol. Lett. 62:37-41.
13. Han, J., and R. J. Ulevitch. 2005. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 6:1198-1205.
14. Hussain, M., S. Ichihara, and S. Mizushima. 1980. Accumulation of glyceride-containing precursor of the outer membrane lipoprotein in the cytoplasmic membrane of Escherichia coli treated with globomycin. J. Biol. Chem. 255:3707-3712.
15. Ichihara, S., M. Hussain, and S. Mizushima. 1981. Characterization of new membrane lipoproteins and their precursors of Escherichia coli. J. Biol. Chem. 256:3125-3129.
16. Ichihara, S., M. Hussain, and S. Mizushima. 1982. Mechanism of export of outer membrane lipoproteins through the cytoplasmic membrane in Escherichia coli. Binding of lipoprotein precursors to the peptidoglycan layer. J. Biol. Chem. 257:495-500.
17. Imanishi, T., H. Hara, S. Suzuki, N. Suzuki, S. Akira, and T. Saito. 2007. TLR2 directly triggers ThI effector functions. J. Immunol. 178:6715-6719.
18. Inukai, M., M. Takeuchi, K. Shimizu, and M. Arai. 1978. Mechanism of action of globomycin. J. Antibiot. (Tokyo) 31:1203-1205.
19. + Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J. Immunol. 172:1786-1800.
20. Kelso, A., and N. M. Gough. 1989. Differential inhibition by cyclosporin A reveals two pathways for activation of lymphokine synthesis in T cells. Growth Factors 1:165-177.
21. Kino, T., M. Nakayama, K. Yasuda, S. Miyakoshi, M. Inukai, and H. Kogen. 2004. Structure-activity relationships of globomycin analogues as antibiotics. Bioorg. Med. Chem. 12:337-361.
22. Kiho, T., M. Nakayama, K. Yasuda, S. Miyakoshi, M. Inukai, and H. Kogen. 2003. Synthesis and antimicrobial activity of novel globomycin analogues. Bioorg. Med. Chem. Lett. 13:2315-2318.
23. Kobayashi, K., K. Kaneda, and T. Kasama. 2001. Immunopathogenesis of delayed-type hypersensitivity. Microsc. Res. Tech. 53:241-245.
24. Lai, J. S., W. M. Philbrick, S. Hayashi, M. Inukai, M. Arai, Y. Hirota, and H. C. Wu. 1981. Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein. J. Bacteriol. 145:657-660.
25. Lee, E. H., and Y. Rikihisa. 1997. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IκB-α and activation of NF-κB. Infect. Immun. 65:2890-2897.
26. Li, J. S., E. Yager, M. Reilly, C. Freeman, G. R. Reddy, A. A. Reilly, F. K. Chu, and G. M. Winslow. 2001. Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis. J. Immunol. 166:1855-1862.
27. Liang, M. D., A. Bagchi, H. S. Warren, M. M. Tehan, J. A. Trigilio, L. K. Beasley-Topliffe, B. L. Tesini, J. C. Lazzaroni, M. J. Fenton, and J. Hellman. 2005. Bacterial peptidoglycan-associated lipoprotein: a naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J. Infect. Dis. 191:939-948.
28. Lin, M., A. den Dulk-Ras, P. J. Hooykaas, and Y. Rikihisa. 2007. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol. 9:2644-2657.
29. Lin, M., and Y. Rikihisa. 2003. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 71:5324-5331.
30. Lin, M., and Y. Rikihisa. 2004. Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-κB, ERK 1/2 and p38 MAPK in host monocytes. Cell. Microbiol. 6:175-186.
31. Lin, M., M. X. Zhu, and Y. Rikihisa. 2002. Rapid activation of protein tyrosine kinase and phospholipase C-γ2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect. Immun. 70:889-898.
32. Maeda, K., N. Markowitz, R. C. Hawley, M. Ristic, D. Cox, and J. E. McDade. 1987. Human infection with Ehrlichia canis, a leukocytic rickettsia. N. Engl. J. Med. 316:853-856.
33. Mott, J., R. E. Barnewall, and Y. Rikihisa. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67:1368-1378.
34. Muller, S. D., M. R. Muller, M. Huber, U. Esche Uv, C. J. Kirschning, H. Wagner, W. G. Bessler, and K. Mittenbuhler. 2004. Triacyl- lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties. Int. Immunopharmacol. 4:1287-1300.
35. Paddock, C. D., and J. E. Childs. 2003. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin. Microbiol. Rev. 16:37-64.
36. Paddock, C. D., J. W. Sumner, G. M. Shore, D. C. Bartley, R. C. Elie, J. G. McQuade, C. R. Martin, C. S. Goldsmith, and J. E. Childs. 1997. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J. Clin. Microbiol. 35:2496-2502.
37. Paetzel, M., A. Karla, N. C. Strynadka, and R. E. Dalbey. 2002. Signal peptidases. Chem. Rev. 102:4549-4580.
38. Rahman, M. S., S. M. Ceraul, S. M. Dreher-Lesnick, M. S. Beier, and A. F. Azad. 2007. The lspA gene, encoding the type II signal peptidase of Rickettsia typhi: transcriptional and functional analysis. J. Bacteriol. 189:336-341.
39. Rikihisa, Y. 1999. Clinical and biological aspects of infection caused by Ehrlichia chaffeensis. Microbes Infect. 1:367-376.
40. Rikihisa, Y. 1997. Ehrlichiae, emerging human pathogens, p. 332-345. In Y. Yanagihara and T. Masuzawa (ed.), Proceedings of the 2nd International Symposium on Lyme Disease. University of Shizuoka, Shizuoka, Japan.
41. Rikihisa, Y., S. A. Ewing, and J. C. Fox. 1994. Western immunoblot analysis of Ehrlichia chaffeensis, E. cants, or E. ewingii infections in dogs and humans. J. Clin. Microbiol. 32:2107-2112.
42. Sander, P., M. Rezwan, B. Walker, S. K. Rampini, R. M. Kroppenstedt, S. Ehlers, C. Keller, J. R. Keeble, M. Hagemeier, M. J. Colston, B. Springer, and E. C. Bottger. 2004. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 52:1543-1552.
43. Schägger, H. 2003. SDS electrophoresis techniques, p. 85-103. In C. Hunte, G. von Jagow, and H. Schägger (ed.), Membrane protein purification and crystallization. Academic Press, San Diego, CA.
44. Sedegah, M., W. Weiss, J. B. Sacci, Jr., Y. Charoenvit, R. Hedstrom, K. Gowda, V. F. Majam, J. Tine, S. Kumar, P. Hobart, and S. L. Hoffman. 2000. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. J. Immunol. 164:5905-5912.
45. Sha, J., S. L. Agar, W. B. Baze, J. P. Olano, A. A. Fadl, T. E. Erova, S. Wang, S. M. Foltz, G. Suarez, V. L. Motin, S. Chauhan, G. R. Kumpel, J. W. Peterson, and A. K. Chopra. 2008. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect. Immun. 76:1390-1409.
46. Sin, J. I., J. J. Kim, K. E. Ugen, R. B. Ciccarelli, T. J. Higgins, and D. B. Weiner. 1998. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur. J. Immunol. 28:3530-3540.
47. Somasundaram, C., H. Takamatsu, C. Andreoni, J. C. Audonnet, L. Fischer, F. Lefevre, and B. Charley. 1999. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immunol. Immunopathol. 70:277-287.
48. Tajima, T., and Y. Rikihisa. 2005. Cytokine responses in dogs infected with Ehrlichia canis Oklahoma strain. Ann. N. Y. Acad. Sci. 1063:429-432.
49. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, S. Akira, M. V. Norgard, J. T. Belisle, P. J. Godowski, B. R. Bloom, and R. L. Modlin. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544-1547.
50. Unver, A., H. Huang, and Y. Rikihisa. 2006. Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis. Ann. N. Y. Acad. Sci. 1078:482-486.
51. Unver, A., Y. Rikihisa, R. W. Stich, N. Ohashi, and S. Felek. 2002. The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts. Infect. Immun. 70:4701-4704.
52. Wellman, M. L., S. Krakowka, R. M. Jacobs, and G. J. Kociba. 1988. A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell. Dev. Biol. 24:223-229.
53. Winslow, G. M., E. Yager, K. Shilo, D. N. Collins, and F. K. Chu. 1998. Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect. Immun. 66:3892-3899.
54. Wormser, G. P., A. Filozov, S. R. Telford III, S. Utpat, R. S. Kamer, D. Liveris, G. Wang, L. Zentmaier, I. Schwartz, and M. E. Aguero-Rosenfeld. 2006. Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis. Vector Borne Zoonotic Dis. 6:388-394.
55. Zhang, X. F., J. Z. Zhang, S. W. Long, R. P. Ruble, and X. J. Yu. 2003. Experimental Ehrlichia chaffeensis infection in beagles. J. Med. Microbiol. 52:1021-1026.